Differential antimicrobial susceptibility between human and chicken isolates of vancomycin-resistant and sensitive Enterococcus faecium

International Journal of Antimicrobial Agents

Volumn 19, Issue 1, 2002, Pages 39-46

  Chen, Han Yuan ^a   Hill, Robert L R ^a   Kirk, Monica ^a   Casewell, Mark W ^a   Beighton, David ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Enterococcus faecium; Human and chicken isolates; Resistance

Indexed keywords

AMOXICILLIN; AVOPARCIN; CHLORAMPHENICOL; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; GENTAMICIN; ORITAVANCIN; STREPTOGRAMIN DERIVATIVE; TEICOPLANIN; TETRACYCLINE; TYLOSIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CARCASS; CHICKEN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; ENTEROCOCCUS FAECIUM; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; CHICKENS; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 0036163879     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(01)00471-X     Document Type: Article

References (40)

1. Emergence of enterococcus as a significant pathogen
2. Serious infection caused by multiply-resistant Enterococcus faecium
3. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium
4. High-level vancomycin-resistant enterococci causing hospital infections
5. The life and times of the Enterococcus
6. The emergence of Enterococcus faecium resistant to glycopeptides and other standard agents - A preliminary report
7. National nosocomial surveillance (NNIS) system report, data summary from January 1990-May 1999, issued June 1999
8. Emergence and nosocomial transmission of ampicillin-resistant enterococci
9. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteraemia: Comparison of clinical features and outcomes
10. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms
11. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes with the VanA cluster
12. Farm animals as a putative reservoir for vancomycin-resistant enterococci infection in man
13. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium
14. VanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry
15. High prevalence of colonisation with vancomycin- and pristinamycin-resistant enterococci in healthy humans and pigs in The Netherlands: Is the addition of antibiotics to animal feeds to blame?
16. The use of subtherapeutic antibiotics in animal feed and its implications on human health
17. Isolation of vancomycin-resistant enterococci from supermarket poultry
18. Vancomycin resistance and antibiotic susceptibility of enterococci in raw meat
19. Nosocomial enterococci resistant to vancomycin, United States, 1998-1993
20. Communicable Disease Report. Vancomycin resistance in enterococci
21. Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR
22. Epidemiology of vancomycin resistant Enterococcus faecium infections in a liver transplant unit
23. Phenotypic differentiation of human and poultry vancomycin-resistant Enterococcus faecium
24. Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium
25. Vancomycin-resistant enterococci isolated from animals and food
26. Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci
27. The in-vitro activity of LY333328, a new glycopeptide, against clinical isolates of vancomycin-resistant enterococci
28. Current perspectives on glycopeptide resistance
29. Isolation of resistant Enterococcus spp. from poultry transport units in the United States and Western Europe
30. Historical yearly usage of vancomycin
31. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance
32. Decrease of vancomycin-resistant enterococci in poultry meat after avoparcin ban
33. Increasing resistance to β-lactam antibiotics among clinical isolates of Enterococcus faecium: A 22-year review at one institution
34. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe
35. Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid-1999
36. Antimicrobial resistance in enterococci isolated from turkey flocks fed virginiamycin
37. Varient esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals
38. Varient esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals
39. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance
40. Disease transmission dynamics and the evolution of antibiotic resistance in hospitals and communal settings